Impact of COVID-19 on the worsening crisis of chronic kidney disease: the imperative to fund early detection is now

被引：2

作者：

Dwyer, Karen M. ^{[1
,2
,3
]}

Sum, Caitlin ^{[1
]}

Johnson, David W. ^{[1
,4
,5
,6
,7
]}

机构：

[1] Kidney Hlth Australia, Melbourne, Vic, Australia

[2] Deakin Univ, Sch Med, Locked Bag 20000, Geelong, Vic 3220, Australia

[3] Epworth Geelong, Internal Med Clin Inst, Geelong, Vic, Australia

[4] Australian & New Zealand Soc Nephrol, Sydney, SA, Australia

[5] Univ Queensland, Div Med, Brisbane, Qld, Australia

[6] Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld, Australia

[7] Translat Res Inst, Ctr Kidney Dis Res, Brisbane, Qld, Australia

来源：

INTERNAL MEDICINE JOURNAL | 2022年 / 52卷 / 04期

关键词：

COVID-19; chronic kidney disease; early detection;

D O I：

10.1111/imj.15670

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The number of Australians affected by kidney disease will increase as the impacts of COVID-19 infection on kidney health are realised. Chronic kidney disease (CKD) imposes significant health and economic burdens from dialysis costs, loss of employment, premature death and increased admissions to hospital. Screening for kidney disease must be integrated into post-COVID-19 care; however, currently there is no reimbursement for kidney health checks in primary care. Early detection can reduce the progression of CKD by as much as 50% and thus the imperative to fund the Kidney Health Check is now.

引用

页码：680 / 682

页数：3

共 19 条

[1]

[Anonymous], 2021, AUSTR GOVT VACCINATI

[2] Kidney Outcomes in Long COVID [J].

Bowe, Benjamin ;

Xie, Yan ;

Xu, Evan ;

Al-Aly, Ziyad .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (11) :2851-2862

[3]

Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI [10.1128/CMR.00028-20, 10.1038/s41432-020-0088-4]

[4] Cost of dialysis therapies in rural and remote Australia - a micro-costing analysis [J].

Gorham, G. ;

Howard, K. ;

Zhao, Y. ;

Ahmed, A. M. S. ;

Lawton, P. D. ;

Sajiv, C. ;

Majoni, S. W. ;

Wood, P. ;

Conlon, T. ;

Signal, S. ;

Robinson, S. L. ;

Brown, S. ;

Cass, A. .

BMC NEPHROLOGY, 2019, 20 (1)

[5] A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases [J].

Jager, Kitty J. ;

Kovesdy, Csaba ;

Langham, Robyn ;

Rosenbergl, Mark ;

Jha, Vivekanand ;

Zoccali, Carmine .

KIDNEY INTERNATIONAL, 2019, 96 (05) :1048-1050

[6]

Johnson David W, 2012, Med J Aust, V197, P224

[7] Evidence-based guide to slowing the progression of early renal insufficiency [J].

Johnson, DW .

INTERNAL MEDICINE JOURNAL, 2004, 34 (1-2) :50-57

[8] Hospitalisation among vaccine breakthrough COVID-19 infections [J].

Juthani, Prerak, V ;

Gupta, Akash ;

Borges, Kelly A. ;

Price, Christina C. ;

Lee, Alfred, I ;

Won, Christine H. ;

Chun, Hyung J. .

LANCET INFECTIOUS DISEASES, 2021, 21 (11) :1485-1486

[9]

Kidney Health Australia, 2020, N Engl J Med, V4th ed.

[10]

Kidney Health Australia, 2020, ANN REV

← 1 2 →